sPLA2-X has been shown to inhibit the replication of tropic HIV-1 CCR and CXCR in human CD4+ T cells (T-helper cells, which are white blood cells that play a principal role in protecting the body from infection) and potentially reduce gene transfer among HIV-1 envelope pseudotyped viral vectors. This evidence concerns the gene CD4 and infection.